Key result
Regional radiofrequency catheter ablation guided by non-contact mapping achieved acute success in 84.4% of ARVC patients with ventricular tachycardias.
Why the study?
Does regional radiofrequency catheter ablation guided by non-contact mapping prevent ventricular tachycardia recurrence in patients with arrhythmogenic right ventricular cardiomyopathy?
Observational (n=32)
Does regional radiofrequency catheter ablation guided by non-contact mapping prevent ventricular tachycardia recurrence in patients with arrhythmogenic right ventricular cardiomyopathy?
Regional radiofrequency catheter ablation guided by non-contact mapping is highly effective and safe for abolishing or improving ventricular tachyarrhythmias in patients with ARVC.
Answers are grounded in this paper and cite their sources.
Supports regional ablation with non-contact mapping for ARVC VT; leaves open confirmation of sustained benefit in randomized trials.
BACKGROUND: Intracardiac non-contact mapping provides a rapid and accurate isopotential mapping that facilitates catheter ablation of the ventricular tachyarrhythmias in arrhythmogenic right ventricular cardiomyopathy (ARVC). METHODS: Thirty-two consecutive patients (26 men and 6 women, mean 37.2 +/- 13.8 years) were treated with ablation. Fourteen patients had a history of syncope/pre-syncope. Two patients had an implantable cardiac defibrillator (ICD) previously implanted. RESULTS: There were 67 ventricular tachycardias (VTs) induced in the 32 patients. The average VT rate was 210 +/- 32.2 (130-310) bpm. There were 42 episodes of VT that had a heart rate > or =200 bpm and 24 of the 32 patients (75%) had > or =2 morphologies of VT. Regional ablation was applied by targeting the earliest VT activation sites under the guidance of non-contact mapping. Acute success was achieved in 84.4% (27/32) patients, and significant improvement was seen in 15.6% (5/32) patients as evidenced by a slower rate of VT. None of the patients experienced syncope/pre-syncope or sudden death during the 28.6 +/- 16 (9-72) month follow-up. There were no complications of the procedure. At the end of follow-up, 81.3% of the patients were free of VT without medication while the rest of the patients achieved a modified success. CONCLUSIONS: The rapid ventricular tachyarrhythmias in ARVC patients can be abolished or improved significantly by regional RF catheter ablation under the guidance of non-contact mapping. There was no sudden cardiac arrest or death in those patients without ICD implantation. Delayed efficacy may occur in some patients after ablation.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2007) conducted an observational in Arrhythmogenic right ventricular cardiomyopathy (ARVC) with ventricular tachyarrhythmias (n=32). Regional radiofrequency catheter ablation guided by non-contact mapping was evaluated on Acute success. Regional radiofrequency catheter ablation guided by non-contact mapping achieved acute success in 84.4% of ARVC patients with ventricular tachycardias.
Synapse has enriched 10 related papers. Consider them for comparative context: